secwatch / observer
8-K/A filed February 2, 2024, 6:59 PM ET CIK 0001860782
leadership confidence high sentiment neutral materiality 0.70

2seventy bio appoints William Baird as CEO and Victoria Eatwell as CFO effective at closing

2seventy bio, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Victoria Eatwell

Chief Financial Officer
2seventy bio, Inc.
Filed
February 2, 2024, 6:59 PM ET
the Board appointed Victoria Eatwell as the chief financial officer of the Company, effective as of the date of the Closing.
Role change

William D. Baird, III

President and Chief Executive Officer
2seventy bio, Inc.
Filed
February 2, 2024, 6:59 PM ET
the Board appointed William D. Baird, III as the president and chief executive officer of the Company, effective as of the date of the Closing.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Victoria Eatwell was appointed as Chief Financial Officer at 2seventy bio, Inc..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
the Board appointed Victoria Eatwell as the chief financial officer of the Company, effective as of the date of the Closing.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

William D. Baird, III was appointed as President and Chief Executive Officer at 2seventy bio, Inc..

Action
appointed
Role
President and Chief Executive Officer
Exact text from the filing
the Board appointed William D. Baird, III as the president and chief executive officer of the Company, effective as of the date of the Closing.
View on SEC.gov
Source: SEC EDGAR
accession 0001860782-24-000009
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.